Ads
related to: Kesimpta- What Is KESIMPTA®?
Learn How KESIMPTA® Works
Read Important Information
- Jamie-Lynn Sigler's Story
Read Jamie-Lynn Sigler's Journey
And Her Experience With KESIMPTA®
- Financial Resources
See If You Qualify For Assistance
With Alongside™ KESIMPTA®.
- Patient Resources
Download Brochures And Watch
Demo Video To Learn More.
- Taking KESIMPTA®
Watch A Video Demonstration
On How KESIMPTA® Is Taken.
- KESIMPTA® Safety
Understand Possible Side
Effects & Safety Information.
- What Is KESIMPTA®?
Search results
Novartis (NVS) Q1 Earnings, Sales Beat, Guidance Raised
Zacks· 3 days agoFree Report) reported better-than-expected results for the first quarter of 2024. Core earnings (excluding one-time charges) of $1.80 per share beat the Zacks Consensus Estimate of $1.73 and ...
Novartis raises guidance after beating Q1 expectations By Reuters
Investing.com· 3 days agoFRANKFURT (Reuters) -Swiss drugmaker Novartis (LON:0QLR) raised its full-year guidance on wider use...
Novartis lifts FY guidance after Q1 results beat expectations
WHTC 1450 Holland· 3 days agoBy Ludwig Burger FRANKFURT (Reuters) -Swiss drugmaker Novartis on Tuesday raised its full-year...
UPDATE 4-Novartis raises guidance after beating Q1 expectations
Reuters via Yahoo Finance· 3 days agoSwiss drugmaker Novartis raised its full-year guidance on wider use of psoriasis and arthritis drug Cosentyx on Tuesday and said it had tapped the former boss of Bristol Myers Squibb (BMS) to ...
The Zacks Analyst Blog Highlights Novartis, American Express, ConocoPhillips, Netflix and...
Zacks· 3 days agoApril 23, 2024 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the ...
Ads
related to: Kesimpta